20 Result(s)

Article

The prognostic potential of monitoring disease dynamics in NPM1-positive acute myeloid leukemia

H. Hoffmann, C. Thiede, I. Glauche, M. Kramer, C. Röllig, G. Ehninger… in Leukemia (2019)

Article

Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide

Therapy-related acute promyelocytic leukemia (t-APL) is relatively rare, with limited data on outcome after treatment with arsenic trioxide (ATO) compared to standard intensive chemotherapy (CTX). We evaluated...

S Kayser, J Krzykalla, M A Elliott, K Norsworthy, P Gonzales, R K Hills… in Leukemia (2017)

Article

Evolution of NPM1-negative therapy-related myelodysplastic syndromes following curative treatment of NPM1-mutant AML

S Herold, K Sockel, C Sayehli, R Herbst, U Dührsen, U Oelschlägel, A Böttner… in Leukemia (2017)

Article

Lenalidomide, adriamycin, dexamethasone for induction followed by stem-cell transplant in newly diagnosed myeloma

S Knop, C Langer, M Engelhardt, L-O Mügge, A Reichle, W Rösler, F Bassermann… in Leukemia (2017)

Article

Donor cell leukemia: evidence for multiple preleukemic clones and parallel long term clonal evolution in donor and recipient

S Herold, M Kuhn, M v Bonin, T Stange, U Platzbecker, J Radke, T Lange… in Leukemia (2017)

Article

Acute myeloid leukemia in the elderly is characterized by a distinct genetic and epigenetic landscape

P Silva, M Neumann, M P Schroeder, S Vosberg, C Schlee, K Isaakidis… in Leukemia (2017)

Article

Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the study alliance leukemia

DNA methylation changes are a constant feature of acute myeloid leukemia. Hypomethylating drugs such as azacitidine are active in acute myeloid leukemia (AML) as monotherapy. Azacitidine monotherapy is not cur...

C Müller-Tidow, P Tschanter, C Röllig, C Thiede, A Koschmieder, M Stelljes… in Leukemia (2016)

Article

Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial

In patients with relapsed or refractory (r/r) acute myeloid leukemia (AML), long-term disease control can only be achieved by allogeneic hematopoietic stem cell transplantation (HSCT). We studied the safety an...

J M Middeke, R Herbst, S Parmentier, G Bug, M Hänel, G Stuhler… in Leukemia (2016)

Article

Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial

The optimal timing of allogeneic hematopoietic stem cell transplantation (HCT) in acute myeloid leukemia (AML) is controversial. We report on 1179 patients with a median age of 48 years who were randomized upf...

J Schetelig, M Schaich, K Schäfer-Eckart, M Hänel, W E Aulitzky, H Einsele… in Leukemia (2015)

Article

Early intervention with allogeneic hematopoietic cell transplantation during chemotherapy-induced aplasia in patients with high-risk acute myeloid leukemia

F Stölzel, U Platzbecker, B Mohr, C Röllig, J M Middeke, C Thiede, M Füssel… in Leukemia (2013)

Article

Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trial

Patients with secondary acute myeloid leukemia (sAML) are generally thought to have a poor prognosis. As there are no prognostic risk stratification models for patients with sAML available, the aim of this stu...

F Stölzel, M Pfirrmann, W E Aulitzky, M Kaufmann, H Bodenstein, M Bornhäuser… in Leukemia (2011)

Article

Methodik und Entwicklungsprozess der S3-Leitlinie zum Prostatakarzinom

Trotz der hohen Inzidenz und einer durch verschiedene Optionen zur Primärtherapie gegebenen Versorgungsvariabilität fehlte in Deutschland bisher eine umfassende Leitlinie zum Prostatakarzinom. Die Deutsche Ges...

Dr. M. Nothacker MPH, C. Röllig, A. Wöckel, I. Kopp, G. Ollenschläger… in Der Urologe (2010)

Article

Entscheidend ist, was ankommt

Diagnose- und Therapieleitlinien sind ein Ansatz zur Verbesserung der Versorgungsqualität. Eine umfangreiche Evaluation des klinischen Effekts urologischer Leitlinien (LL) erfolgte bisher nicht. Fragestellung ...

Dr. J. Busch, C. Röllig, L. Weißbach, C. Kempkensteffen, S. Hinz, C. Jahnke… in Der Urologe (2010)

Article

Early allogeneic blood stem cell transplantation after modified conditioning therapy during marrow aplasia: stable remission in high-risk acute myeloid leukemia

Two patients with high-risk acute myeloid leukemia (AML) whose bone marrow aspirates showed more than 25% blasts between 2 and 4 weeks after the first induction chemotherapy immediately received modified condi...

U Platzbecker, C Thiede, J Freiberg-Richter, C Röllig… in Bone Marrow Transplantation (2001)

Article

Dose-reduced conditioning for allogeneic blood stem cell transplantation: durable engraftment without antithymocyte globulin

Between February 1998 and October 1999, 24 patients with advanced leukemia, lymphoma or solid tumors received G-CSF mobilized peripheral blood stem cells (PBSC) from HLA-matched sibling donors after dose-reduc...

M Bornhäuser, C Thiede, U Schuler, U Platzbecker… in Bone Marrow Transplantation (2000)